author-photo

Joshua K. Sabari

Memorial Sloan Kettering Cancer Center
New York University

56

Papers

1847

Citations

Citation Trend

Filter By

Papers (43) Sort By

Journal Conference Others

Phase II two-arm study of tepotinib plus osimertinib in patients with EGFR-mutant NSCLC and acquired resistance to first-line osimertinib due to MET amplification: INSIGHT 2.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Amivantamab in EGFR exon 20 insertion-mutated non-small-cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Durvalumab consolidation therapy in a patient with stage IIIB unresectable NSCLC harboring a MET exon 14 splice site alteration.

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas.

2021 Modern Pathology
Show All
- Source
- Cite
- Save
Citations (2)
Amivantamab in combination with lazertinib for the treatment of osimertinib-relapsed, chemotherapy-naïve EGFR mutant (EGFRm) non-small cell lung cancer (NSCLC) and potential biomarkers for response.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Dynamic Management of Lung Cancer Care During Surging COVID-19

2021 Frontiers in Surgery
Show All
- Source
- Cite
- Save
Citations (2)
OA04.04 Amivantamab in Post-platinum EGFR Exon 20 Insertion Mutant Non-small Cell Lung Cancer

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (14)
99O_PR KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (Pts) with advanced non–small cell lung cancer (NSCLC) harboring KRASG12C mutation

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (11)
RADI-19. The Incidence of New Brain Metastases in Patients with Non-Small Cell Lung Cancer Following Discontinuation of Systemic Therapy

2021
Show All
- Source
- Cite
- Save
Citations (0)